# Sakar Healthcare stock up 4.5% after Q2 results

> Sakar Healthcare shares rise 4.5% post-Q2 results as experts debate rally continuation.
- Title: Sakar Healthcare stock up 4.5% after Q2 results · mint
- Summary: Sakar Healthcare shares rise 4.5% post-Q2 results as experts debate rally continuation. Sakar Healthcare stock rose 4.5% after reporting 149% YoY net profit…
- Keywords: sakar healthcare, q2 results 2026, net profit, stock market, investors, technical analysis, resistance levels, support zones, news, india, Sakar, Healthcare
- Source: mint — https://livemint.com/market/stock-market-news/multibagger-stock-sakar-healthcare-rises-4-5-after-q2-results-2026-up-500-in-5-years-will-rally-continue-11792998905646.html
- Author: Vaamanaa Sethi
- Published: 2026-10-26T08:16:33+00:00
- Read time: 1 min
- Topics: sakar healthcare, q2 results 2026, net profit, stock market, investors, technical analysis, resistance levels, support zones, news, india
## Sakar Healthcare shares open
Sakar Healthcare shares opened at ₹ 943.50 per share today, compared to ₹ 885 on Friday last week.
## Short-term performance
Sakar Healthcare shares declined 17.81% over the past month but gained 1.12% in the past week.
## Long-term gains
Sakar Healthcare has surged 503.82% over five years, with 182.79% growth in three years.
## Q2 FY27 results
Sakar Healthcare reported 149% YoY net profit growth to ₹ 11.30 crore, with EBITDA rising 114% to ₹ 24.34 crore.
## Q2 FY27 drivers
Growth driven by new oncology approvals, robust demand across geographies, improved product mix, and cost management.
## H1 FY27 results
Sakar Healthcare recorded 134% YoY net profit growth to ₹ 21.59 crore, with EBITDA rising 90% to ₹ 45.59 crore.
## Management statement
Sanjay Shah, Managing Director, said Q2 FY27 brought meaningful progress in oncology with regulatory approvals and global market access.
## Lemonn technical view
Gaurav Garg notes the stock is trading around ₹ 943.40 after rebounding from ₹ 870, 880 support, with ₹ 980 as key resistance.
## Kantilal Chhaganlal Securities view
Mahesh M Ojha identifies ₹ 824, 800 as crucial support and ₹ 980 as immediate resistance for Sakar Healthcare.
## Key takeaway

Sakar Healthcare stock rose 4.5% after reporting 149% YoY net profit growth in Q2 FY27, with analysts debating whether the rally will continue.